Cargando…
Microvesicles as Emerging Biomarkers and Therapeutic Targets in Cardiometabolic Diseases
Microvesicles (MVs, also known as microparticles) are small vesicles that originate from plasma membrane of almost all eukaryotic cells during apoptosis or activation. MVs can serve as extracellular vehicles to transport bioactive molecules from their parental cells to recipient target cells, thereb...
Autores principales: | Chen, Yan, Li, Guangping, Liu, Ming-Lin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6000161/ https://www.ncbi.nlm.nih.gov/pubmed/29462670 http://dx.doi.org/10.1016/j.gpb.2017.03.006 |
Ejemplares similares
-
Microvesicles/exosomes as potential novel biomarkers of metabolic diseases
por: Müller, Günter
Publicado: (2012) -
Microvesicles as Potential Ovarian Cancer Biomarkers
por: Giusti, Ilaria, et al.
Publicado: (2013) -
Endothelial microvesicles in hypoxic hypoxia diseases
por: Deng, Fan, et al.
Publicado: (2018) -
Microvesicles as a potential biomarker of neoplastic diseases and their role in development and progression of neoplasm
por: Kajdos, Magdalena, et al.
Publicado: (2015) -
Microvesicles: Novel Biomarkers for Neurological Disorders
por: Colombo, Elisa, et al.
Publicado: (2012)